Cancer Molecular Diagnostics
| Full details for "BRCA - Combined". | |
|---|---|
Name |
BRCA - Combined |
Alternative name/Profile |
|
Department |
Cancer Molecular Diagnostics |
Investigation |
Prediction of PARPi response in selected conditions |
Specimen type |
Peripheral blood & formalin fixed paraffin embedded tissue |
Sample type |
|
Sample container & volume |
3-5ml in EDTA (purple top) tubes |
Frequency of analysis |
Weekly |
Turnaround time |
20-30 working days |
Availability |
Monday - Friday, 9:30am to 5pm |
Notes |
Test requests must be accompanied by a completed BRCA test request and consent form. Include one copy of the request form with the blood sample. Forward a second copy of the form to the histopathology laboratory for block selection. A histopathology report should be provided with the block. A neoplastic cell content of >30% is required. If the neoplastic cell count is estimated to be <30%, an area on the H&E slide should be marked for maccrodissection. Any H&E slide provided will be retained by the CMD laboratory. Blood sample(s) should be sent at room temperature as soon as possible after collection. Refrigerate if there will be more than a 24 hr delay before posting. DO NOT FREEZE. |
Related links |
|
Reference range |
|
Last updated |
Tue, 17 Feb 2026 07:59:16 GMT |